OUR PUBLICATIONS
2025
Placental malaria: a systematic review and meta-analysis of global burden, risk factors, and maternal and foetal outcomes.
Menon S, D'Alessio F, Chaudhuri N, Onwuchekwa C, Kaur M, Nkumama I, Olesen OF.
J Glob Health. 2025 Nov 28;15:04355.
2025
Incidence and antimicrobial resistance of non-typhoidal Salmonella enterica in stool samples from children under five in peri-urban Ouagadougou, Burkina Faso.
Héma A, Soulama BI, Sawadogo J, Ouédraogo AZ, Hien D, Nébié I, Houard S, Ouédraogo A, Tiono AB, Sanou M, Sirima SB.
BMC Microbiol. 2025 Nov 24;25(1):784.
2025
Seroprevalence of antibodies to Plasmodium falciparum transmission-blocking target proteins Pfs230D1M and Pfs48/45 in Tanzanian populations of diverse malaria transmission intensity.
Mulamba C, Kalinga WF, Mtaka I, Lazaro LO, Kamage J, Nkumama I, Odufuwa OG, Kreppel K, Mekhaiel D, Miura K, Long CA, Olotu AI, Williams C.
Front Immunol. 2025 Sep 11;16:1589061.
2025
Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies - A stakeholder meeting report.
Meln I, Cnossen V, Corti N, Andeweg A, Baay M, Chiu C, Coia J, Cornely O, Cox RJ, Dasyam D, De Keersmaecker SCJ, Deming M, Waldock J, Engelhardt OG, Guo M, Haj-Ali Saflo O, Hensen A, Jeeninga R, Kolstoe S, Krut O, Kuijper EJ, Leal L, Mazur N, Mohn KGI, Morel S, Osterhaus A, Moreira AP, Smits WK, Sridhar S, Toomey D, van Gerven J, Vehreschild MJGT, Yarzabal JP, Zimmer-Harwood P, Neels P, Olesen OF, Roestenberg M, Kamerling IMC.
Biologicals. 2025 May;90:101818
2025
Advancing regulatory dialogue: In silico models for improved vaccine biomanufacturing - an expert meeting report.
Meln I, Van Molle W, Vélez MP, Abrahamsen G, Brusselmans K, Calvosa E, Cardillo AG, Clénet D, Forestieri C, Gernaey KV, Hoefnagel M, Jorgensen JB, Lebrun P, Natalis L, Nilsson B, Öppling V, Pollinger JC, Rayat ACME, Reem D, Rubbrecht M, Schmölder J, Schofield T, Smith D, Timmins S, von Lieres E, Welin M, Bracewell DG.
Vaccine. 2025 Apr 26;56:127170.
2025
How to develop a controlled human infection model for Clostridioides difficile
Hensen ADO, Vehreschild MJGT, Gerding DN, Krut O, Chen W, Young VB, Tzipori S, Solbach P, Gibani MM, Chiu C, de Keersmaecker SCJ, Dasyam D, Morel S, Devaster JM, Corti N, Kuijper EJ, Roestenberg M, Smits WK.
Microbiol Infect. 2025 Mar;31(3):373-379.
2025
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials.
Venkatraman N, Tiono AB, Bowyer G, Bellamy DG, Stockdale LK, Powlson J, Collins KA, Coulibaly S, Datoo MS, Silman D, Ouedraogo A, Nébié I, Imoukhuede EB, Brod F, Folegatti P, Dickinson-Craig E, Jamieson S, Bougouma EC, Wright D, Diarra A, Bliss CM, Morter R, Glenn G, Fries LF, Reimer JM, Lövgren-Bengtsson K, Baker M, Poulton I, Moyle S, Berrie E, Green N, Mukhopadhyay E, Viebig NK, Angus B, Lawrie A, Roberts R, Gilbert SC, Lewis DJM, Sirima SB, Ewer KJ, Hill AVS.
Lancet Microbe. 2025 Mar;6(3):100868.
2025
Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies - A stakeholder meeting report.
Meln I, Cnossen V, Corti N, Andeweg A, Baay M, Chiu C, Coia J, Cornely O, Cox RJ, Dasyam D, De Keersmaecker SCJ, Deming M, Waldock J, Engelhardt OG, Guo M, Haj-Ali Saflo O, Hensen A, Jeeninga R, Kolstoe S, Krut O, Kuijper EJ, Leal L, Mazur N, Mohn KGI, Morel S, Osterhaus A, Moreira AP, Smits WK, Sridhar S, Toomey D, van Gerven J, Vehreschild MJGT, Yarzabal JP, Zimmer-Harwood P, Neels P, Olesen OF, Roestenberg M, Kamerling IMC.
Biologicals. 2025 Jan 16;90:101818.
2025
Safety, Tolerability, and Immunogenicity of the InvaplexAR-DetoxShigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial.
Roozen GVT, Sukwa N, Chirwa M, White JA, Estrada M, Maier N, Turbyfill KR, Laird RM, Suvarnapunya AE, Sayeh A, D'Alessio F, Marion C, Pattacini L, Hoogerwerf MA, Murugan R, Terrinoni M, Holmgren JR, Sirima SB, Houard S, Simuyandi M, Roestenberg M.
Vaccines (Basel). 2025 Jan 8;13(1):48.
2024
Boosting Vaccine Research: The 16-Year Journey of TRANSVAC Vaccine Infrastructure.
Martin W, Luís C, Jungbluth S, Slezak M, Verreck FAW, Spiegel H, Guzman CA, Roldão A, Carrondo MJT, Van der Ley P, Segalés J, Dockrell HM, Ho MM, Pedersen GK, Lawrenz M, Olesen OF.
Vaccines (Basel). 2024 Dec 22;12(12):1446